Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer.
Wu Z, Zhao G, Zhang Z, Shen C, Wang L, Xu G, Zhao Y, Liang R, Li C, Liu H, Wang H, Dong H, Fu H, Li M, Li H, Zhuang Y, Da L, Huang S, Jia K, Chen H, Bai Y, Guo S, Cheng H, Wang H, Wang H, Niu Y, Hu H.
Wu Z, et al. Among authors: bai y.
Eur Urol Oncol. 2024 May 17:S2588-9311(24)00110-X. doi: 10.1016/j.euo.2024.04.020. Online ahead of print.
Eur Urol Oncol. 2024.
PMID: 38762368
Free article.